Status:
COMPLETED
Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)
Lead Sponsor:
Schering-Plough
Conditions:
Hepatitis C, Chronic
Hepacivirus
Eligibility:
All Genders
18+ years
Brief Summary
The current gold standard for treatment of chronic hepatitis C is pegylated interferon plus ribavirin. Drug administration accuracy and ease of use will definitely determine treatment effectiveness. T...
Eligibility Criteria
Inclusion
- Patients with chronic hepatitis C treated with the PegIntron pen plus Rebetol
Exclusion
- Not willing to participate in the study
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT00705263
Start Date
October 1 2005
End Date
May 1 2008
Last Update
August 25 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.